🔎 Trials Near Me

Home › Asthma › Massachusetts

Pag-aaral pangklinika para sa Asthma sa Massachusetts

16 pag-aaral para sa Asthma ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 144, North Dartmouth
Nagre-recruitPhase 3
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07276724

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • Research Site, Boston
  • Research Site, Boston
Nagre-recruitPhase 3
Edad 5 hanggang 11 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06023589

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Boston
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06307665

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT00595491

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  • Brigham and Women's Hospital, Boston
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07219173

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

  • Boston Specialists, Boston
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07746687

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  • Research Site 20, Fall River
Nagre-recruitPhase 3
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07359846

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Worcester
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Boston
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07301255

Registry of Asthma Characterization and Recruitment 3 (RACR3)

  • Boston Children's Hospital: Department of Immunology, Boston
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05272241

A Study of CDX-622 in Participants With Mild to Moderate Asthma

  • Brigham and Women's Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07330778

Protocol CAUSE-03 / CHEETAH

  • Boston University School of Medicine: Pulmonary Center, Boston
  • Boston Children's Hospital: Department of Immunology, Boston
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06136091

Asthma Link Effectiveness Trial

  • University of Massachusetts Chan Medical School, Worcester
Nagre-recruit
Edad 5 hanggang 14 · Lahat ng kasarian · Na-update May 5, 2026 · NCT06388460

Home Hospital for Suddenly Ill Adults

  • Brigham and Women's Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT03524222

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • Reliant Medical Group, Worcester
Nagre-recruitPhase 4
Edad 13 hanggang 75 · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT07052942

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.